Korea Joongang Daily
Korea JoongAng Daily

Korean firms 'exploring options' as Trump's pharma tariffs loom

Tensions rise in Korea's pharma sector as Trump plans drug tariffs. Companies like Samsung Biologics monitor the situation while the government opposes potential U.S. measures.

2025-05-06

CMG Pharma's Mezofy gets first U.S. FDA approval for changed form for Korea

Mezofy, an oral film-type medication for treating schizophrenia developed by CMG Pharmaceutical, received approval from the U.S. Food and Drug Administration, a first for a change to medication form for a Korean firm.

2025-04-16

As tariffs slam the world, one Korean industry slides under the radar

Korean biopharmaceutical firms have found temporary relief after being spared the “reciprocal” tariffs U.S. President Donald Trump announced Wednesday.

2025-04-04

FTC probes pharmacy lobby's office over potential Daiso supply meddling

The Fair Trade Commission launched an on-site probe of the Korean Pharmaceutical Association on allegations that the group illegally interfered with Daiso's supply of products from three manufacturers.

2025-03-13

Daiso pulls hyped-up health supplements on pharmacist opposition

Dollar shop chain Daiso no longer sells some of its hyped up health supplements following opposition from pharmacists, leading to a potential probe from Korea’s market watchdog to see if the latter’s actions violate fair trade laws.

2025-03-11

Fation boosts presence in Southeast Asia with expansion into Guardian stores

Dong-A Pharmaceutical, led by CEO Baek Sang-hwan, announced earlier this month that its derma cosmetics brand, Fation, has entered Guardian, a health and beauty store chain in Malaysia and Singapore.

2025-02-18

Celltrion to roll out record cash and stock dividends

Korean drugmaker Celltrion said Friday it will hand out its biggest-ever cash and stock dividends to its shareholders as part of efforts to boost shareholder value.

2024-12-13

CEO of Japan's largest biotech cluster touts growing opportunities for Korean startups

“However, with the recent improvements in the relationship between Japan and Korea, a new route into the U.S. through the Asian market has emerged,” said Fujimoto.

2024-10-09

Hanmi Pharma chief survives ousting attempt by late founder's son

Hanmi Pharmaceutical chief executive Park Jae-hyun retained his top post in the company, fending off an attempt by Lim Jong-yoon, the late founder’s son, to oust him as the family feud continues.

2024-09-02

Daewoong sets $745 million sales target for duo of new drugs

BARCELONA, Spain — Daewoong Pharmaceutical hopes to achieve $745 million in global sales with its new drugs Fexuclue, a gastroesophageal reflux medication, and Envlo, a diabetes treatment, by 2030.

2023-10-26